Basophilic Leukemia

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia [Phase 2]

  A Phase 2 clinical trial evaluating the combination of decitabine, cytarabine, and daunorubicin hydrochloride for treatment of Acute Myeloid…

• CLINICAL_TRIALS research · 2016-05-19
  Clinical Trial Update: Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia

  A completed pediatric AML biomarker study update from the Children's Oncology Group examining biomarkers in bone marrow from high-risk AML p…

• CLINICAL_TRIALS trial_result · 2015-04-15
  Clinical Trial Update: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase [Phase 1]

  This update summarizes a Phase 1 study of tipifarnib and bortezomib in patients with acute leukemia and blast-phase chronic myeloid leukemia…

• CLINICAL_TRIALS trial_result · 2013-02-08
  Clinical Trial Update: XK469R in Treating Patients With Refractory Hematologic Cancer [Phase 1]

  Phase 1 trial update reporting initial safety and tolerability findings for XK469R in patients with refractory hematologic cancers.

• CLINICAL_TRIALS trial_result · 2013-01-24
  Clinical Trial Update: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

  Phase 2 trial of idarubicin and cytarabine with or without bevacizumab for newly diagnosed acute myeloid leukemia was terminated.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.